News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The ASCO TECAG is hard at work, getting ready for ASCO 2024
Photo taken from ASCO TECAG/X
Jan 17, 2024, 07:59

The ASCO TECAG is hard at work, getting ready for ASCO 2024

ASCO TECAG shared the following post on X/Twitter:

“The ASCO TECAG is hard at work, getting ready for ASCO 2024! If you’re interested in joining this phenomenal group of oncologists, consider applying! Deadline: January 31, 2024 for the 2024-2025 cohort.”

Additional information.

Source: ASCO TECAG/X

ASCO 2024 ASCO TECAG cancer OncoDaily Oncology
Insight
Aug 10, 2024, 11:10
Shahrin Ahmed: Multiple myeloma treatment with Darzalex Faspro has been approved by the FDA
Insight
Aug 10, 2024, 10:25
The critical need to control systemic disease in breast cancer patients who have received stereotactic radiosurgery to brain metastases - Wilmot Cancer Institute
Blog
Aug 10, 2024, 10:15
Sami Mansfield: The impact of delivering a remote coaching program of lifestyle interventions
Blog
Aug 10, 2024, 10:03
The importance of continuing raising money to fund the best and brightest researchers - Conquer Cancer
Blog
Aug 10, 2024, 09:52
Oncoinfluencers to Follow on Social Media: Dr. Sachin Jain
Insight
Aug 10, 2024, 09:37
Jarrod Dudakov: The emergence of atypical epithelial cells in the thymus with age
Blog
Aug 10, 2024, 09:34
Margaret Foti is the recipient of the 2024 Beacon Award for Women Leaders in Oncology
Blog
Aug 10, 2024, 09:14
Angie Smith: Our final celebratory PCORI, Cistostudy annual meeting at Bladder Cancer Advocacy Network Think Tank
Societies
Aug 10, 2024, 09:08
12 Posts Not To Miss From Day 2 of ASCOBT24!
Blog
Aug 10, 2024, 08:58
Manel Esteller: Knowledge driven by Technology
Blog
Aug 10, 2024, 08:54
Robin Zon: Spending time with the bright and talented leaders in ASCO’s Asia Pacific Leadership Development Program
Blog
Aug 10, 2024, 08:21
Susan Pandya: The beginning of a new era for patients living with grade 2 IDH-mutant glioma